PURPOSE: In certain cancers, MDM2 SNP309 has been associated with early tumor onset in women. In melanoma, incidence rates are higher in women than in men among individuals less than 40 years of age, but among those older than 50 years of age, melanoma is more frequent in men than in women. To investigate this difference, we examined the association among MDM2 SNP309, age at diagnosis, and gender among melanoma patients. EXPERIMENTAL DESIGN: Prospectively enrolled melanoma patients (N = 227) were evaluated for MDM2 SNP309 and the related polymorphism, p53 Arg72Pro. DNA was isolated from patient blood samples, and genotypes were analyzed by PCR-restriction fragment length polymorphism. Associations among MDM2 SNP309, p53 Arg72Pro, age at diagnosis, and clinicopathologic features of melanoma were analyzed. RESULTS: The median age at diagnosis was 13 years earlier among women with a SNP309 GG genotype (46 years) compared with women with TG+TT genotypes (59 years; P = 0.19). Analyses using age dichotomized at each decade indicated that women with a GG genotype had significantly higher risks of being diagnosed with melanoma at ages <50 years compared with women >or=50 years, but not when the comparison was made between women <60 and >or=60 years. At ages <50 years, women with a GG genotype had a 3.89 times greater chance of being diagnosed compared with women with TG+TT genotypes (P = 0.01). Similar observations were not seen among men. CONCLUSIONS: Our data suggest that MDM2 may play an important role in the development of melanoma in women. The MDM2 SNP309 genotype may help identify women at risk of developing melanoma at a young age.
PURPOSE: In certain cancers, MDM2SNP309 has been associated with early tumor onset in women. In melanoma, incidence rates are higher in women than in men among individuals less than 40 years of age, but among those older than 50 years of age, melanoma is more frequent in men than in women. To investigate this difference, we examined the association among MDM2SNP309, age at diagnosis, and gender among melanomapatients. EXPERIMENTAL DESIGN: Prospectively enrolled melanomapatients (N = 227) were evaluated for MDM2SNP309 and the related polymorphism, p53 Arg72Pro. DNA was isolated from patient blood samples, and genotypes were analyzed by PCR-restriction fragment length polymorphism. Associations among MDM2SNP309, p53 Arg72Pro, age at diagnosis, and clinicopathologic features of melanoma were analyzed. RESULTS: The median age at diagnosis was 13 years earlier among women with a SNP309 GG genotype (46 years) compared with women with TG+TT genotypes (59 years; P = 0.19). Analyses using age dichotomized at each decade indicated that women with a GG genotype had significantly higher risks of being diagnosed with melanoma at ages <50 years compared with women >or=50 years, but not when the comparison was made between women <60 and >or=60 years. At ages <50 years, women with a GG genotype had a 3.89 times greater chance of being diagnosed compared with women with TG+TT genotypes (P = 0.01). Similar observations were not seen among men. CONCLUSIONS: Our data suggest that MDM2 may play an important role in the development of melanoma in women. The MDM2SNP309 genotype may help identify women at risk of developing melanoma at a young age.
Authors: David Polsky; Kate Melzer; Carole Hazan; Katherine S Panageas; Klaus Busam; Maria Drobnjak; Hideko Kamino; Joanna G Spira; Alfred W Kopf; Alan Houghton; Carlos Cordon-Cardo; Iman Osman Journal: J Natl Cancer Inst Date: 2002-12-04 Impact factor: 13.506
Authors: Hongbing Shen; Zhensheng Liu; Sara S Strom; Margaret R Spitz; Jeffrey E Lee; Jeffrey E Gershenwald; Merrick I Ross; Paul F Mansfield; Madeleine Duvic; Honnavara N Ananthaswamy; Qingyi Wei Journal: J Invest Dermatol Date: 2003-12 Impact factor: 8.551
Authors: Ronit I Yarden; Eitan Friedman; Sally Metsuyanim; Tsviya Olender; Edna Ben-Asher; Moshe Zvi Papa Journal: Breast Cancer Res Treat Date: 2007-11-18 Impact factor: 4.872
Authors: Lukasz F Grochola; Jorge Zeron-Medina; Sophie Mériaux; Gareth L Bond Journal: Cold Spring Harb Perspect Biol Date: 2009-12-09 Impact factor: 10.005
Authors: Pei-Yi Lin; Lishi Sun; Suzanne R Thibodeaux; Sara M Ludwig; Ratna K Vadlamudi; Vincent J Hurez; Rumana Bahar; Mark J Kious; Carolina B Livi; Shawna R Wall; Lieping Chen; Bin Zhang; Tahiro Shin; Tyler J Curiel Journal: J Immunol Date: 2010-08-04 Impact factor: 5.422
Authors: Gurinder Singh Atwal; Tomas Kirchhoff; Elisabeth E Bond; Marco Montagna; Marco Monagna; Chiara Menin; Roberta Bertorelle; Maria Chiara Scaini; Frank Bartel; Anja Böhnke; Christina Pempe; Elise Gradhand; Steffen Hauptmann; Kenneth Offit; Arnold J Levine; Gareth L Bond Journal: Proc Natl Acad Sci U S A Date: 2009-06-04 Impact factor: 11.205
Authors: Zhiqiang Zeng; Jennifer Richardson; Daniel Verduzco; David L Mitchell; E Elizabeth Patton Journal: Zebrafish Date: 2009-12 Impact factor: 1.985